Objective To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic
drop in patients with dry eye disease (DED) associated with meibomian gland dysfunction …

Purpose To evaluate the efficacy and safety of NOV03 (perfluorohexyloctane) ophthalmic
drop for the treatment of signs and symptoms of dry eye disease (DED) associated with …

Purpose: NOV03 has a unique dual mode of action to address dry eye disease (DED)
associated with meibomian gland dysfunction. SEECASE evaluated the efficacy, safety, and …

Meibomian gland dysfunction (MGD) is highly prevalent and is the leading cause of
evaporative dry eye disease (DED). MGD is characterized by a reduction in meibum …

Purpose: Evaporation of the tear film is heavily discussed as one core reason for dry eye
disease (DED). Subsequently, new artificial tear products are developed that specifically …

Purpose To evaluate the efficacy and safety of OC-01 (varenicline solution) nasal spray for
treatment of patients with dry eye disease. Design Randomized, multicenter, double …

OBJECTIVE: To investigate the dose-dependent efficacy and safety of diquafosol ophthalmic
solution for the treatment of dry eye syndrome. DESIGN: Randomized, double-masked …

Purpose Dry eye disease is characterized by loss of tear film stability. OC-01 (varenicline
solution) is a small-molecule nicotinic acetylcholine receptor agonist administered as a …

Dry eye disease (DED) is a multifactorial and complex disease of the ocular surface, with a
high prevalence in adults. We systematically reviewed efficacy and safety data from …

Introduction: Dry eye is a visually disabling disease encountered in many countries with a
wide variation of treatment practices all over the world. On that front, the 2007 Report of the …